Description

Glimepirid-TEVA Tablets 2 mg. №30

Ingredients:

Each tablet contains 2 mg of Glimepiride as the active ingredient. Inactive ingredients include microcrystalline cellulose, povidone, sodium starch glycolate, and magnesium stearate.

Dosage:

The usual starting dose is 1-2 mg once daily with breakfast or the first main meal. Dosage adjustments should be made based on blood glucose levels. The maximum recommended dose is 8 mg per day.

Indications:

Glimepirid-TEVA tablets are indicated for the treatment of type 2 diabetes mellitus. They help lower blood sugar levels by stimulating the release of insulin from the pancreas.

Contraindications:

Do not use Glimepirid-TEVA tablets in patients with type 1 diabetes, diabetic ketoacidosis, or a history of hypersensitivity to sulfonylureas. Caution is advised in patients with renal or hepatic impairment.

Directions:

Take Glimepirid-TEVA tablets exactly as prescribed by your healthcare provider. It is usually taken once daily with food. Monitor blood sugar levels regularly as directed.

Scientific Evidence:

Studies have shown that Glimepiride, the active ingredient in Glimepirid-TEVA tablets, effectively lowers blood glucose levels in patients with type 2 diabetes.

Clinical trials have demonstrated the efficacy of Glimepiride in improving glycemic control and reducing HbA1c levels.

Additional Information:

It is important to follow a healthy diet and exercise regimen while taking Glimepirid-TEVA tablets to achieve optimal results.

Consult your healthcare provider for personalized advice on managing your diabetes and medication regimen.